Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes

Erinmarie O. Kimbrough, Liuyan Jiang, Ephraim E. Parent, Kirk Bourgeois, Muhamad Alhaj Moustafa, Han W. Tun, Muhamad Alhaj Moustafa

Research output: Contribution to journalArticlepeer-review


Diffuse large B-cell lymphoma (DLBCL) is well known for selectively involving certain extranodal locations such as the central nervous system (CNS), testes, and skin. DLBCL or high-grade B-cell lymphoma selectively involving the bone marrow is rare and has been sparsely reported in the medical literature. We report two cases of lymphoma presenting with primary bone marrow involvement without evidence of involvement of any other sites. The first case represents de novo DLBCL. The patient achieved complete remission with initial treatment, had a bone marrow-only relapse three years later, and achieved a second complete remission following non-transplant salvage therapy. The second case had findings consistent with “double hit” Richter’s transformation of chronic lymphocytic leukemia with translocation of c-MYC and BCL-2. This patient had an aggressive clinical course characterized by rapid progression with CNS involvement within three months resulting in the demise of the patient. These two cases represent two distinct subtypes of primary bone marrow lymphoma: de novo and transformed. Further research is necessary to gain a better understanding of this rare lymphoma entity and develop novel therapies.

Original languageEnglish (US)
Pages (from-to)663-671
Number of pages9
JournalJournal of Blood Medicine
StatePublished - Nov 1 2022


  • bone marrow involvement
  • cytopenias
  • diffuse large B-cell lymphoma
  • high-grade B-cell lymphoma with MYC and BCL-2 rearrangements

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Primary Bone Marrow Lymphoma: De Novo and Transformed Subtypes'. Together they form a unique fingerprint.

Cite this